Biogen BIIB
NASDAQ BIIB
$250.69 -3.15 (-1.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Biogen (BIIB) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

Biogen (BIIB) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Biogen 37.04 Bn 23.70 Bn 1.96 Bn 1.52 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Bn
Mar 31, 2026 625.70 Mn
Dec 31, 2025 100,000.00
Sep 30, 2025 56.60 Mn
Dec 31, 2024 -358.80 Mn
Sep 30, 2024 39.20 Mn
Jun 30, 2024 408.70 Mn
Mar 31, 2024 55.60 Mn
Dec 31, 2023 -8.16 Bn
Sep 30, 2023 5.70 Bn
Jun 30, 2023 2.13 Bn
Mar 31, 2023 440.50 Mn
Dec 31, 2022 -4.10 Bn
Sep 30, 2022 1.64 Bn
Jun 30, 2022 1.91 Bn
Mar 31, 2022 543.60 Mn
Dec 31, 2021 -2.03 Bn
Sep 30, 2021 575.40 Mn
Jun 30, 2021 633.50 Mn
Mar 31, 2021 1.73 Bn
API Access

Biogen Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEY